XML 30 R21.htm IDEA: XBRL DOCUMENT
v3.21.1

Revenue | 3 Months Ended
--- | ---
Mar. 31, 2021
Revenue from Contract with Customer [Abstract] |
REVENUE | 14. REVENUE We primarily offer the First Defense® product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the three-month period ended March 31, 2021 or the year ended December 31, 2020. We do not have any contract assets for which we have satisfied the performance obligations but do not yet have the right to bill for or contract liabilities such as customer advances. All trade receivables on our balance sheets are from contracts with customers. We incur no material costs to obtain contracts. The following table presents our product sales disaggregated by geographic area:
|  | During the Three-Month Periods Ended March 31, |  |  | During the Years Ended December 31, |
|  | 2021 |  |  | % |  |  | 2020 |  |  | % |  |  | 2020 |  |  | % |  |  | 2019 |  |  | % |
United States |  | $ | 3,580,516 |  |  |  | 87 | % |  | $ | 4,357,682 |  |  |  | 89 | % |  | $ | 13,644,768 |  |  |  | 89 | % |  | $ | 12,191,108 |  |  |  | 89 | %
Other |  |  | 526,630 |  |  |  | 13 | % |  |  | 552,706 |  |  |  | 11 | % |  |  | 1,697,436 |  |  |  | 11 | % |  |  | 1,531,764 |  |  |  | 11 | %
Total Product Sales |  | $ | 4,107,146 |  |  |  | 100 | % |  | $ | 4,910,388 |  |  |  | 100 | % |  | $ | 15,342,204 |  |  |  | 100 | % |  | $ | 13,722,872 |  |  |  | 100 | %
The following table presents our product sales disaggregated by major product category:
|  | During the Three-Month Periods Ended March 31, |  |  | During the Years Ended December 31, |
|  | 2021 |  |  | % |  |  | 2020 |  |  | % |  |  | 2020 |  |  | % |  |  | 2019 |  |  | % |
First Defense® product line |  | $ | 4,023,471 |  |  |  | 98 | % |  | $ | 4,819,191 |  |  |  | 98 | % |  | $ | 15,072,446 |  |  |  | 98 | % |  | $ | 13,244,396 |  |  |  | 97 | %
Other animal health |  |  | 83,675 |  |  |  | 2 | % |  |  | 91,197 |  |  |  | 2 | % |  |  | 269,758 |  |  |  | 2 | % |  |  | 344,875 |  |  |  | 2 | %
Other(1) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 133,601 |  |  |  | 1 | %
Total Product Sales |  | $ | 4,107,146 |  |  |  | 100 | % |  | $ | 4,910,388 |  |  |  | 100 | % |  | $ | 15,342,204 |  |  |  | 100 | % |  | $ | 13,722,872 |  |  |  | 100 | %
| (1) | Sales outside of the United States included $133,601 of non-animal health sales during the first quarter of 2019, which product has since been divested.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI http://asc.fasb.org/topic&trid=49130388 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration